Delivery Order SPE2DB20D3103-SPE2DB24FQ1R9

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,565,058,079 units of the naloxone 2 mg/2 ml syringe 2 ml to the U.S. Defense Department's Medical Supply Chain. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The firm-fixed-price delivery order has a ceiling value of $3,293.72 and an ultimate completion date of July 3, 2024. The contract is not set aside and was awarded directly by the Defense Logistics...
This federal contract award is for the delivery of 4,562,321,643 units of 2 mg/2 ml naloxone syringes to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a total ceiling value of $1,268.10. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,050.92, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the delivery of 4,567,731,395 units of naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,118,754 units of the drug naloxone 2 mg/2 ml syringe, with a ceiling value of $6,448.79. The contract is a firm fixed-price delivery order, with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,112.79 firm fixed-price delivery order is for the supply of 4,562,548,382 units of 2 mg/2 mL naloxone syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency Troop Support Medical. The $1,760.71 firm fixed price delivery order is for the supply of 4,566,328,555 units of 2 mg/2 ml naloxone syringes. The contract has a completion date of November 5, 2024 and was awarded on November 4, 2024. There is no set-aside designation for this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the...
This federal contract award, valued at $1,085.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4564957174, NALOXONE 2 MG/2 ML SYRINGE 2ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This is a federal contract award issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,255.77 firm fixed-price delivery order is for the supply of 4,567,473,255 units of 2 mg/2 ml naloxone syringes. The award has an ultimate completion date of March 6, 2025 and was issued on March 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $1,029.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566787603 NALOXONE 2 MG/2 ML SYRINGE 2ML, a critical medication used for the treatment of opioid overdose. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,915,824 units of the pharmaceutical product Naloxone 2 mg/2 ml syringe. The contract has a ceiling value of $2,832.71 and a completion date of January 14, 2025. It is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ1R9
    Delivery Order

This federal contract award, valued at $3,300.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,694,878 units of Naloxone 2 mg/2 ml syringes, with an ultimate completion date of September 6, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:56 AM